Concurring with the Biden Administration, the US Supreme Court rejected an agreement with Purdue Pharma that proposed to settle all outstanding claims regarding its fraudulent marketing of the opioid Oxycontin, the Associated Press reports.
The agreement to end the class action suit would have shielded the controlling Sackler family from civil lawsuits regarding the wealth they amassed while making people addicts, and it would have allowed the company to reform after emerging from bankruptcy protections. Both the administration and the Justice Department objected to the amnesty the deal gave the Sacklers.